An outbreak of Nipah virus has occurred in India, and Jinhao Pharmaceutical’s all‑premixed nucleic acid assay combined with colloidal gold antigen tests is supporting epidemic monitoring and control.
发布时间：2026.01.26
According to foreign media reports, recently, an outbreak has occurred in West Bengal, India. Nipah virus outbreak. At present, there are five confirmed cases, including healthcare workers. Feeling… The infected individuals are receiving treatment at a hospital, with one patient in critical condition, and nearly 100 people have been placed under home quarantine.
Thailand, Nepal, and several other countries have stepped up surveillance and response measures to the epidemic, with Phuket International Airport intensifying health screenings for travelers arriving from India.
At present, no related cases have been reported in China, and the Law of the People’s Republic of China on Frontier Health Quarantine, revised and adopted in 2024, makes no mention of this virus.
What is Nipah virus disease?
Nipah virus disease (NVD) is by Nipah virus (NiV) A zoonotic infectious disease caused by the virus. It typically manifests as acute respiratory symptoms such as fever, cough, and dyspnea, or as neurological signs including headache, dizziness, altered consciousness, and seizures, and may even result in death. The case-fatality rate of human infection with Nipah virus can be as high as 40%–75%, or even higher.
01
Clinical symptoms
The incubation period is generally 4–14 days . Human infection with Nipah virus disease A certain proportion of infections are asymptomatic. 。
Typical cases often present with fever and predominantly manifest as severe respiratory symptoms such as pharyngeal pain, cough, dyspnea, and acute respiratory distress syndrome, along with headache, dizziness, vomiting, decreased muscle tone, nuchal rigidity, seizures, and varying degrees of consciousness disturbance, progressing within 24–48 hours to neurological symptoms including coma.
02
Host animals and sources of infection
Fruit bat It is the natural reservoir of the Nipah virus, primarily distributed in South Asia, Southeast Asia, and Australia. In China, Yunnan, Guangxi, Guangdong, and Hainan Fruit bats are also found in these regions.
The intermediate hosts of the Nipah virus are primarily Pig , in addition there is also Horses, sheep, cats, and dogs Wait for the animals.
The primary sources of infection for human Nipah virus disease are primarily Animals and humans infected with the virus 。
03
Routes of transmission
Direct contact with virus-infected animals or their bodily fluids.
Consuming food contaminated by the bodily fluids, secretions, or excreta of animals infected with the virus.
Close contact with infected patients or their bodily fluids. Person-to-person transmission of Nipah virus primarily occurs in Case households and medical institutions 。
There are literature reports of aerosol transmission.
04
Seasonal
Nipah virus disease outbreak Mainly occurs in December to May of the following year.
Jinhao Pharmaceutical possesses “Molecule + Immunity” Dual platform, Nipah Virus All‑In‑One Premixed Nucleic Acid Detection Kit (Fluorescent PCR Method) and Nipah Virus (NiV) Antigen Detection Kit (Colloidal Gold Method) , jointly supporting Nipah virus–related epidemic surveillance and control.
Nipah virus all-in-one multiplex nucleic acid test
01
Nipah virus all-in-one multiplex nucleic acid test
02
Nipah virus antigen detection
Follow us
Phone: 400-650-6787 | 010-67878866 | Address: Building 1, No. 7 Yuncheng Street, Beijing Economic-Technological Development Area, Beijing |
© 2026 Beijing Jinhao Pharmaceutical Co., Ltd. All rights reserved | Beijing ICP Filing No. 17020135-2